Effectiveness of ECA Cream on Calcifying Shoulder Tendinitis
ECA
1 other identifier
interventional
10
1 country
1
Brief Summary
This pilot trail aims to assess the effectiveness of ECA cream in the treatment of calcifying shoulder tendinitis in terms of:
- 1.Reduction or removal of shoulder calcifications
- 2.Functional improvements
- 3.Pain improvements 10 subjects will be assessed prior and 1 and 2 months post intervention onset. The intervention will consist in the application of the ECA cream in the affected shoulder twice a day during 1 month.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2016
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2016
CompletedFirst Submitted
Initial submission to the registry
November 28, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2016
CompletedFirst Posted
Study publicly available on registry
December 7, 2016
CompletedJanuary 31, 2017
January 1, 2017
Same day
November 28, 2016
January 30, 2017
Conditions
Outcome Measures
Primary Outcomes (2)
Presence of shoulder calcifications
X-ray
2 months
Size of shoulder calcifications
Ultrasonography
2 months
Secondary Outcomes (2)
Shoulder functionality
1 and 2 months
Shoulder pain
1 and 2 months
Study Arms (1)
Intervention
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- patients \>=18 years
- diagnosed of calcifying shoulder tendinitis diagnosed by a medical specialist (rehabilitation, orthopedic surgeon or rheumatologist) by x-ray
- with disease evolution of more than 3 months and less than 12 months
- that give their informed consent by writing
You may not qualify if:
- Previous shoulder surgery patients
- Patients with shoulder affections treated with shockwaves or corticosteroid injections.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Consorci Sanitari del Maresmelead
- PRODUCTOS SANITARIOS ECA-RVB SLIcollaborator
Study Sites (1)
Consorci Sanitari del Maresme
MatarĂ³, Barcelona, 08304, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD
Study Record Dates
First Submitted
November 28, 2016
First Posted
December 7, 2016
Study Start
October 1, 2016
Primary Completion
October 1, 2016
Study Completion
December 1, 2016
Last Updated
January 31, 2017
Record last verified: 2017-01
Data Sharing
- IPD Sharing
- Will not share